Loading Events

« All Events

  • This event has passed.

The Current and Future State of Healthcare

June 7, 2021 @ 4:00 pm - 5:00 pm

$650

Program Description

This advanced program focuses on how fundamental features of the healthcare landscape are changing.  The topics discussed go into detail on:

  • Controlling product access​
  • Stakeholders in product distribution​​
  • Carving out financial risk
  • The growing role of IDNs​

Program Structure

Upon registration, you will be assigned a set of e-learning courses to complete prior to the live webinar. These courses will detail key topics impacting market access today: ​

  • The IDN Business Model​
  • Marketplace Pressures​​
  • The Evolving Payer Business Model

The live discussion pulls through concepts learned and demonstrates real-world examples. Come prepared to think constructively about your business environment as it relates to the topics discussed.​


What to Expect​

Once you purchase a MAP Program, you will receive 3 emails from ProFusion MAP:​

  • Welcome! Learning Awaits​
    • This email will provide you with account information for access to the MAP Program you registered for​
  • Register for…
    • This email will list all available live webinar sessions for the MAP Program you purchased​
    • Sessions are closed to registration after the 10-person max is reached. Sign up early!​
  • You’re enrolled in…​
    • This email will direct you to the MAP Program with all e-learning courses to complete before your live session​
    • These courses are only available for 90 days after your purchase date. You are encouraged to complete all courses prior to the live session​

​Tip: You can save the ProFusion MAP LMS to your bookmark for quick access!​

If you have any questions, contact ProFusion MAP Support at +1 877-369-2580​

Stay Updated on New MAP Programs and Dates

As the market access environment changes, relevant topics will be covered through new programs. Subscribe below to be the first to know about new MAP Program topics and added dates for existing Programs.

*required





    Privacy Guaranteed — We will never share your info!

    Manufacturers Restricting 340B Sales to Contract Pharmacies

    • Abbvie
    • Amgen
    • AstraZeneca
    • Boehringer Ingelheim
    • Eli Lilly
    • Merck
    • Novartis
    • Novo Nordisk
    • Sanofi
    • UCB
    • United Therapeutics
    • and more…